Results 231 to 235 of about 2,449,966 (235)

Efficacy and safety of osilodrostat in patients with ectopic Cushing´s syndrome. a real-world study in Spain.

Journal of Endocrinological Investigation
M. Araujo-Castro, Rogelio Garcia-Centeno, L. González Fernández, A. Soto-Moreno, Rosa Cámara, M. D. Ollero García, Ana Irigaray Echarri, Paola Gracia, E. Pascual-Corrales, B. Biagetti, Andrés Cardona, I. González Molero, A. Simó-Servat, F. Guerrero-Pérez, R. Villar-Taibo, I. Bernabéu, Carmen Fajardo-Montañana, C. Novo-Rodríguez, C. Tenorio-Jiménez, María Calatayud, M. D. Moure Rodríguez, Fernando Cordido, Ana Castro, Lucía Manzano Valero, M. Paja, J. Goi, A. Aulinas, Pablo Abellán, Pedro Iglesias, F. Hanzu   +29 more
semanticscholar   +1 more source

Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.

The Lancet Diabetes and Endocrinology, 2014
G. Di Dalmazi, V. Vicennati, S. Garelli, Elena Casadio, E. Rinaldi, E. Giampalma, C. Mosconi, R. Golfieri, A. Paccapelo, U. Pagotto, R. Pasquali   +10 more
semanticscholar   +1 more source

DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).

European Journal of Endocrinology, 2017
J. Findling, H. Raff
semanticscholar   +1 more source

Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome.

Journal of Clinical Endocrinology and Metabolism, 1960
G. Liddle
semanticscholar   +1 more source

Update and practical recommendations for the use of medical treatment of Cushing´s syndrome.

Endocrine reviews
M. Araujo-Castro, Cristina Lamas, E. Nowak, J. Newell-Price, M. Reincke, F. Castinetti   +5 more
semanticscholar   +1 more source